Results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma Meeting Abstract
| Authors: | Herrera, A. F.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; Ogden, C. A.; Taft, D.; Zhang, Q.; Kato, K.; Campbell, M.; Advani, R. H. |
| Abstract Title: | Results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401296 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.649.649 |
| Notes: | Meeting Abstract: 649 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
